BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 24725690)

  • 1. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.
    Alexander BM; Wechsler D; Braun TM; Levine J; Herman J; Yanik G; Hutchinson R; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1191-6. PubMed ID: 15978741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Low-Dose Cranial Boost on the Long-Term Outcomes of Adult Patients with High-Risk Acute Lymphoblastic Leukemia Undergoing Total Body Irradiation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Famoso JM; Grow JL; Laughlin B; Katsanis E; Stea B
    Pract Radiat Oncol; 2019 May; 9(3):e283-e289. PubMed ID: 30578956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmenting Total Body Irradiation with a Cranial Boost before Stem Cell Transplantation Protects Against Post-Transplant Central Nervous System Relapse in Acute Lymphoblastic Leukemia.
    Gao RW; Dusenbery KE; Cao Q; Smith AR; Yuan J
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):501-506. PubMed ID: 29191665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
    Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
    Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
    Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
    J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.
    Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.
    Quaranta BP; Halperin EC; Kurtzberg J; Clough R; Martin PL
    Cancer; 2004 Aug; 101(4):845-50. PubMed ID: 15305418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cranial boost in high-risk adult acute lymphoblastic leukemia patients undergoing bone marrow transplant.
    Su W; Thompson M; Sheu RD; Steinberg A; Isola L; Stock R; Bakst RL
    Pract Radiat Oncol; 2017; 7(2):103-108. PubMed ID: 28274393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
    Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
    Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
    Croog VJ; Kramer K; Cheung NK; Kushner BH; Modak S; Souweidane MM; Wolden SL
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):849-54. PubMed ID: 20207502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.